Moderna shares are trading higher amid strength in vaccine stocks due to concerns over rising COVID cases.
Portfolio Pulse from Benzinga Newsdesk
Moderna's stock is trading higher due to increased concerns over rising COVID-19 cases, which is strengthening vaccine stocks.
August 22, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Moderna's stock is expected to rise in the short term due to increased demand for vaccines amid rising COVID-19 cases.
The rising COVID-19 cases have led to increased demand for vaccines, which is positively impacting Moderna's stock. As Moderna is a major vaccine producer, its stock is expected to rise in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100